References
- GOLD Scientific Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Update 2014. Available at http://goldcopd.org/
- Qaseem A, Wilt TJ, Weinberger, SE et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011;155:179-91
- Cazzola M, Puxeddu E, Bettoncelli G, et al. The prevalence of asthma and COPD in Italy: a practice-based study. Respir Med 2011;105:386-91
- Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32
- De Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004;59:120-5
- Donaldson GC, Wedzicha JA. The causes and consequences of seasonal variation in COPD exacerbation. Int J COPD 2014:9;1101-10
- Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012;39:38-45
- Bettoncelli G, Blasi F, Brusasco V, et al. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidisciplinary Respir Med 2014;9:25
- GOLD Scientific Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Update 2008. Available at http://goldcopd.org/
- GOLD Scientific Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Update 2011. Available at http://goldcopd.org/
- Drivenes E, Ostrem A, Melbye H. Predictors of ICS/LABA prescribing in COPD patients: a study from general practice. BMC Fam Pract 2014;15:42
- D'Urzo A, Donohue JF, Kardos P, et al. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opin Pharmacother 2015;16:1845-60
- Price D, Yawn B, Brusselle G, et al. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J 2013;22:92-100
- Schweiger TA, Zdanowicz M. Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Health Syst Pharm 2010;67:1061
- Katz P, Pegoraro V. L’utilizzo dei corticosteroidi nei pazienti con la broncopneumopatia cronica ostruttiva: aspetti epidemiologici ed economici. Farmacoeconomia e percorsi terapeutici 2009;10;139-48
- Ripellino C, Guasconi A, Heiman F. L’impatto dell’aderenza alle linee guida GOLD sul budget del SSN negli anni, in un mercato in continuo cambiamento. Farmacoeconomia Health Economics and Therapeutic Pathways 2014;15:5-14
- Annemans L, Aristides M, Kubin M. Real-Life Data: A Growing Need. The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research. Available at: http://www.ispor.org/news/articles/oct07/rld.asp [Last accessed 11 December 2014]
- Maio S, Baldacci S, Martini F, et al. COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners. Curr Med Res Opin 2014;30:1033-42
- Corrado A, Rossi A. How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med 2012;106:989-97
- Caramori G, Bettoncelli G, Tosatto R, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis 2005;63:6-12
- Jebrak G. COPD routine management in France: are guidelines used in clinical practice? Revue des Maladies Respiratoires 2010;27:11-18
- Overington JD, Huang YC, Abramson MJ, et al. Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions. J Thorac Dis 2014;6:1586-96
- Davis KJ, Landis SH, Oh YM, et al. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J COPD 2015:10:39-55
- L’uso dei farmaci in Italia – Rapporto OsMed 2012. Agenzia Italiana del Farmaco. Osservatorio nazionale dell’impiego dei medicinali, 2012. Available at: http://www.agenziafarmaco.gov.it/it/content/luso-deifarmaci-italia-rapporto-osmed-2012
- Dietlein G, Schroder-Bernhardi D. Use of the mediplus patient database in healthcare research. Int J Clin Pharmacol Ther 2002;40:130-3